|
Activity Number:
|
77
- Contributed Poster Presentations: Biopharmaceutical Section
|
|
Type:
|
Contributed
|
|
Date/Time:
|
Monday, August 3, 2020 : 10:00 AM to 2:00 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
|
Abstract #313899
|
|
|
Title:
|
Statistical Analysis Considerations for Clinical Outcome Assessments Based Endpoints
|
|
Author(s):
|
Chul Ahn*
|
|
Companies:
|
FDA-CDRH
|
|
Keywords:
|
patient experience ;
clinical outcome assessment;
estimand
|
|
Abstract:
|
We need to obtain meaningful patient data to understand patients’ experience with their disease and its treatment. This talk will discuss how to develop endpoint measures to assess clinical outcomes important to both patients and caregivers and how to properly analyze those endpoints.
|
Authors who are presenting talks have a * after their name.
